Ofer Yodfat

This inventor holds 126 USPTO granted patents and 29 published patent applications and 71 EPO patents, primarily in Drug Delivery Systems (CPC class A61M5-14248). Top assignees: Roche Diabetes Care, Inc., Roche Diagnostics Operations, Inc., Medingo Ltd.. Active years: 2002-2026.

USPTO Granted Patents = 126 (Patent Applications = 29)

% Patents Active = 81.7

EPO Patents = 71 (Patent Applications = 86)

Average Co-Inventor Count = 2.7

ph-index = 30

Forward Citations = 5,184(Granted Patents)

Forward Citations (Not Self Cited) = 4,789(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Reut, IL (2002 - 2007)
Maccabim-Reut, IL (2008 - 2021)
Modi'in, IL (2004 - 2023)

Company Filing History:

39 out of 664

Roche Diabetes Care, Inc.

patents

33 out of 1,696

Roche Diagnostics Operations, Inc.

Triple Jump Israel Ltd.

8. 2 out of 834,411

Other

patents

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Drug Delivery

Fluid Infusion

Patch Pumps

Embolic Protection

Therapeutic Fluids

Insulin Delivery

Medical Devices

Fluid Dispensing

Diabetes Management

Implant Delivery

Sustained Delivery

Monitoring Systems

126 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12636428 - Systems, apparatuses and methods for fluid infusion into a body (2026-05-26),

2. 12214156 - Systems, methods, apparatuses and devices for drug or substance delivery (2025-02-04),

3. 12168113 - Patch pump systems and apparatus for managing diabetes, and methods thereof (2024-12-17),

4. 11596733 - Patch pump systems and apparatus for managing diabetes, and methods thereof (2023-03-07),

5. 11554209 - Systems, apparatuses and methods for fluid infusion into a body (2023-01-17),

6. 11484397 - Systems and methods for implant delivery (2022-11-01),

7. 11419790 - Automatic device for transferring fluid (2022-08-23),

8. 11207170 - Systems, methods and devices for embolic protection (2021-12-28),

9. 11202699 - Systems, methods and devices for embolic protection (2021-12-21),

10. 11179514 - Systems, devices and methods for sustained delivery of a therapeutic fluid (2021-11-23),

11. 11090430 - Vented dispensing device and method (2021-08-17),

12. 11090427 - Device for drug delivery (2021-08-17),

13. 11077244 - Fluid dispensing device with a flow detector (2021-08-03),

14. 10925708 - Monofilament implants and systems for delivery thereof (2021-02-23),

15. 10603432 - Method and system for adaptive communication transmission (2020-03-31),

Title: Innovation in Diabetes Management: The Ingenious Mind of Ofer Yodfat

Introduction:

Ofer Yodfat, a prolific inventor based in Maccabim-Reut, IL, is at the forefront of revolutionizing diabetes management with his groundbreaking patents and ingenious solutions. With an impressive portfolio of 123 patents, Yodfat's work is shaping the future of healthcare technology, particularly in the realm of insulin delivery systems.

Latest Patents:

Yodfat's latest patents include innovative patch pump systems and apparatus for managing diabetes. These cutting-edge systems, devices, and methods are designed to streamline insulin delivery to patients in a portable and efficient manner. By miniaturizing patch pumps, Yodfat is making diabetes management more convenient and accessible.

Additionally, Yodfat's patent on fluid infusion devices represents a significant advancement in diabetes care. The portable fluid infusion device he developed consists of a disposable part and a reusable part, offering a cost-effective and user-friendly solution for patients requiring insulin therapy.

Career Highlights:

Having worked at renowned companies such as Roche Diabetes Care, Inc. and Roche Diagnostics Operations, Inc., Yodfat has honed his skills and expertise in the field of medical device innovation. His keen insights and creative problem-solving abilities have led to the development of transformative technologies that are improving the lives of individuals with diabetes worldwide.

Collaborations:

Yodfat's collaborative spirit is evident in his associations with esteemed colleagues such as Avraham Neta and Gali Shapira. Together, they have contributed to the advancement of diabetes management technology, fostering a culture of innovation and excellence within the industry.

Conclusion:

In conclusion, Ofer Yodfat's groundbreaking inventions in diabetes management underscore his dedication to improving patient outcomes and enhancing healthcare technology. His inventive spirit, coupled with his extensive experience in the field, positions him as a visionary figure in the realm of medical device innovation. With a focus on portable, user-friendly solutions, Yodfat is paving the way for a more efficient and accessible approach to diabetes care.